Clinical-Stage Biotech Company - 15 Patents (Immunotherapy/Cancer)
1350 Avenue of the Americas, New York, NY - 10019
Description
Clinical-stage biotechnology company focusing on the development of cutting edge, virus-driven immunotherapies for difficult-to-treat cancers. 15 granted patents protecting the intellectual property behind drugs and Immunotherapy process in the U.S, Canada, Europe and Asia. Heavily Differentiated and patented Immunology approach with progressive drugs. Significant cash flow potential both internally and through out-licensing products.
Documents
Unlock Due Diligence by signing the Confidentiality Agreement.
Auction Information
- Executive Summary
- Bid Procedures
- Notice of Potential Contract Assumption & Assignment
- Notice of Sale
- Notice of Modified Auction Sale Dates
Due Diligence Information
Terms & Conditions
-
Buyers Premium
NA (see Bidding Procedures)
-
Closing
Later of (i) 30-days of Auction; and (ii) 15 days after Court approval. See Bidding Procedures.
-
Deposit Amount
10% of Bid Amount. See Bidding Procedures.
-
Broker Co-op
NA
Inspection
Qualifying Bid Deadline: November 17, 2023 @ 12:00 PM ET
Auction Location:
On-Site